Here are four things to know:
1. The Subchondroplasty technology is used in minimally invasive outpatient interventions.
2. It aims to address the defects associated with subchondral bone marrow lesions.
3. Zimmer Biomet acquired the Subchondroplasty technology in 2013.
4. Zimmer Biomet now owns sixteen patents and eight trademarks in this area.
More articles on devices:
5 observations on Amedica shares dropping by 15.92%
Global MIS market to grow to $50B+ by 2019: 7 key trends
ExactechGPS launches globally: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
